Fate Therapeutics Inc Earnings

The next earnings date for Fate Therapeutics Inc is July 30, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Fate Therapeutics Inc Earnings

Report DateEstimated Earnings Per Share
10/30/2025$-0.34
07/30/2025$-0.34

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Fate Therapeutics Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
05/07/2025After Market$-0.3215.66%
02/24/2025Before Market$-0.44-3.82%
11/06/2024Before Market$-0.402.96%
08/13/2024After Market$-0.3331.25%
05/09/2024After Market$-0.474.08%
02/26/2024After Market$-0.4513.46%
11/08/2023After Market$-0.4619.30%
08/08/2023After Market$-0.548.47%
05/03/2023After Market$-0.1969.35%
02/28/2023After Market$-0.5832.56%
11/03/2022After Market$-0.863.37%
08/03/2022After Market$-0.794.82%
05/04/2022After Market$-0.6811.69%
02/28/2022After Market$-0.72-7.46%
11/04/2021After Market$-0.4522.41%
08/04/2021After Market$-0.58-9.43%
05/05/2021After Market$-0.48-11.63%
02/24/2021After Market$-0.61-56.41%
11/05/2020After Market$-0.68-88.89%
08/05/2020After Market$-0.35-29.63%
05/11/2020After Market$-0.44-12.82%
03/02/2020After Market$-0.375.13%
11/05/2019After Market$-0.40-5.26%
08/06/2019After Market$-0.36-9.09%
05/07/2019After Market$-0.30-25.00%
03/05/2019After Market$-0.25-4.17%
11/01/2018After Market$-0.31-24.00%
08/06/2018After Market$-0.37-15.63%
05/10/2018After Market$-0.27-22.73%
03/05/2018After Market$-0.29-20.83%
11/01/2017After Market$-0.26-8.33%
08/14/2017After Market$-0.234.17%
05/15/2017After Market$-0.24-20.00%
03/16/2017After Market$-0.2127.59%
11/07/2016After Market$-0.273.57%
08/08/2016After Market$-0.296.45%
05/09/2016After Market$-0.29-16.00%
03/03/2016After Market$-0.263.70%
11/03/2015After Market$-0.2420.00%
08/05/2015After Market$-0.3315.38%
05/07/2015After Market$-0.38-5.56%
03/12/2015After Market$-0.303.23%
11/11/2014After Market$-0.309.09%
08/12/2014---$-0.3018.92%
05/13/2014---$-0.34-3.03%
03/17/2014---$-0.29-7.41%
11/13/2013---$-4.81-1,403.13%

More About Fate Therapeutics Inc

Country
USA
Full Time Employees
181

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Fate Therapeutics Inc Earnings” Can Refer to the Fate Therapeutics Inc Earnings Date

Some people say “Fate Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Fate Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Fate Therapeutics Inc Stock on the Earnings Date

If you own Fate Therapeutics Inc stock (FATE) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Fate Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Fate Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Fate Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Fate Therapeutics Inc earnings or anything else related to the stock market.